In the study by Cardillo et al., it was presented that blockade of IGF-1 binding to IGF-1R and downregulation of this receptor are equally effective in inhibiting RCC cell lines growth and combined with mTOR inhibitor – temsirolimus works in synergy. The gene discussed is IGF1; the disease is renal cell adenocarcinoma.